T Crepin1,2,3,4, E Gaiffe4,5, C Courivaud1,2,3,4, C Roubiou2,3,4, C Laheurte1,6, B Moulin7, L Frimat8, P Rieu9, C Mousson10, A Durrbach11, A-E Heng12, P Saas1,2,3,5,6, J Bamoulid1,2,3,4, D Ducloux1,2,3,4,5. 1. INSERM, UMR1098, Federation Hospitalo-Universitaire INCREASE, Besançon, France. 2. Faculté de Médecine et de Pharmacie, Université de Franche-Comté, Besançon, France. 3. Structure Fédérative de Recherche, SFR FED4234, Besançon, France. 4. Department of Nephrology, Dialysis, and Renal Transplantation, CHU Besançon, Besançon, France. 5. CIC Biothérapie, INSERM CIC1431, CHU Besançon, Besançon, France. 6. Plateforme de Biomonitoring, EFS Bourgogne Franche-Comté, CIC 1431/UMR1098, Besançon, France. 7. Department of Nephrology, Dialysis, and Renal Transplantation, CHU Strasbourg, Strasbourg, France. 8. Department of Nephrology, Dialysis, and Renal Transplantation, CHU Nancy, Nancy, France. 9. Department of Nephrology, Dialysis, and Renal Transplantation, CHU Reims, Reims, France. 10. Department of Nephrology, Dialysis, and Renal Transplantation, CHU Dijon, Dijon, France. 11. Department of Nephrology, Dialysis, and Renal Transplantation, CHU Kremlin-Bicêtre, Le Kremlin-Bicêtre, France. 12. Department of Nephrology, Dialysis, and Renal Transplantation, CHU Clermont-Ferrand, Clermont-Ferrand, France.
Abstract
BACKGROUND: End-stage renal disease (ESRD) is associated with premature aging of the T-cell system. Nevertheless, the clinical significance of pre-transplant ESRD-related immune senescence is unknown. METHODS: We studied whether immune risk phenotype (IRP), a typical feature of immune senescence, may affect post-transplant infectious complications. A total of 486 patients were prospectively studied during the first year post transplant. IRP was defined as positive cytomegalovirus serology with at least 1 of the following criteria: CD4/CD8 ratio <1 and/or CD8 T-cell count >90th percentile. RESULTS: We found that 47 patients (9.7%) had pre-transplant IRP. IRP+ patients did not differ from IRP- patients for any clinical characteristics, but exhibited more pronounced immune senescence. Both opportunistic infections (43% vs. 6%, P < 0.001) and severe bacterial infection (SBI) (40% vs. 25%, P = 0.028) were more frequent in IRP(+) patients. In multivariate analysis, IRP was predictive of both opportunistic infection (hazard ratio [HR] 2.97 [95% confidence interval {CI} 1.53-5.76], P = 0.001), and SBI (HR 2.33 [95% CI 1.34-3.92], P = 0.008). Acute rejection rates were numerically much lower in IRP+ patients. A total of 418 patients (86%) had biological evaluation 1 year post transplant. Among 41 IRP+ patients, 35 (85%) remained IRP+ 1 year post transplant. CONCLUSION: Pre-transplant IRP is associated with an increased risk of post-transplant infection.
BACKGROUND: End-stage renal disease (ESRD) is associated with premature aging of the T-cell system. Nevertheless, the clinical significance of pre-transplant ESRD-related immune senescence is unknown. METHODS: We studied whether immune risk phenotype (IRP), a typical feature of immune senescence, may affect post-transplant infectious complications. A total of 486 patients were prospectively studied during the first year post transplant. IRP was defined as positive cytomegalovirus serology with at least 1 of the following criteria: CD4/CD8 ratio <1 and/or CD8 T-cell count >90th percentile. RESULTS: We found that 47 patients (9.7%) had pre-transplant IRP. IRP+ patients did not differ from IRP- patients for any clinical characteristics, but exhibited more pronounced immune senescence. Both opportunistic infections (43% vs. 6%, P < 0.001) and severe bacterial infection (SBI) (40% vs. 25%, P = 0.028) were more frequent in IRP(+) patients. In multivariate analysis, IRP was predictive of both opportunistic infection (hazard ratio [HR] 2.97 [95% confidence interval {CI} 1.53-5.76], P = 0.001), and SBI (HR 2.33 [95% CI 1.34-3.92], P = 0.008). Acute rejection rates were numerically much lower in IRP+ patients. A total of 418 patients (86%) had biological evaluation 1 year post transplant. Among 41 IRP+ patients, 35 (85%) remained IRP+ 1 year post transplant. CONCLUSION: Pre-transplant IRP is associated with an increased risk of post-transplant infection.
Authors: Lauren E Higdon; Claire E Gustafson; Xuhuai Ji; Malaya K Sahoo; Benjamin A Pinsky; Kenneth B Margulies; Holden T Maecker; Jorg Goronzy; Jonathan S Maltzman Journal: Front Immunol Date: 2021-05-27 Impact factor: 7.561
Authors: David DeWolfe; Jinal Gandhi; Matthew R Mackenzie; Thomas A Broge; Evelyn Bord; Amaara Babwah; Didier A Mandelbrot; Martha Pavlakis; Francesca Cardarelli; Raphael Viscidi; Anil Chandraker; Chen S Tan Journal: PLoS One Date: 2017-05-31 Impact factor: 3.240
Authors: David DeWolfe; Malika Aid; Kevin McGann; Joshua Ghofrani; Emma Geiger; Catherine Helzer; Shaily Malik; Steve Kleiboeker; Stephanie Jost; Chen Sabrina Tan Journal: Front Immunol Date: 2019-08-23 Impact factor: 7.561